134 Rationale for evaluating (R)-roscovitine (Seliciclib) in patients with cystic fibrosis
Meijer, L., Nelson, D., Riazanski, V., Gabdulkhakova, A.G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., Guéganton, L., Dorothée, G., Gray, R.D., Rossi, A.G., Witko-SarVolume:
14
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/S1569-1993(15)30311-8
Date:
June, 2015
File:
PDF, 67 KB
english, 2015